Members

Temperature Controlled Pharma Products Market| COVID-19 Analysis

Market Research Future (MRFR), asserts that the global Temperature Controlled Pharma Products market is expected to exhibit a CAGR of 9.48% over the forecast period of 2018-2023 and value at USD 8,762.4 million by 2023. Primarily, the increase in number of thermal-sensitive drugs is gaining traction for the market.

Industry News

September 2019

Peli BioThermal, a leader in providing thermal-controlled packaging solutions, exhibited its solution at Defence and Security Equipment International (DSEI) 2019 for the first time.

Segmental Overview

The Temperature Controlled Pharma Products market is segmented by payload capacity, product, type of use, temperature range, type, and end-use industry. By product, the market is divided into insulated containers and insulated shippers. The insulated shippers segment is likely to lead in forecast period.

By type, the market is segmented into passive systems and active systems. The active systems segment is expected to expand at a CAGR of 9.14% over the review period.

By type of use, the market is segmented into reusable and single-use. The single-use segment to direct the market growth.  

By end-use, the market is segmented into clinical trial and pharmaceutical. The pharmaceutical segment is projected to thrive at 10.08% CAGR over the assessment period.

Regional Outlook

Regionally, the Temperature Controlled Pharma Products market has been studied across Europe, Asia Pacific, North America, and the Rest of the World (RoW).

The ever-increasing pharmaceutical industry in North America is expected to impel the market growth in this region. Presence of pharmaceutical regulatory bodies in the region can cast a positive influence on the market. The US market is anticipated to show a healthy growth.

The Europe market is likely to expand by 9.42% over the review period. The existence of robust supply chain logistics is a major factor that is likely to determine the growth of the regional market. Other factors such as development of novel drugs and increase number of contract research organization (CROs) can surge the regional market. Germany to exhibit the highest growth rate.

Key Players

Storopack Hans Reichenecker GmbH, va-Q-tec AG, Sofrigam, DB Schenker, Sonoco ThermoSafe, Cold Chain Technologies, United Parcel Service of America, Inc. (UPS), KUEHNE + NAGEL INC, Softbox Systems Limited, Envirotainer AB, Pelican Bio Thermal, and DHL International GmbH.

Views: 1

Comment

You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service